Paper20882
Two possible roles of bacteriorhodopsin; a comparative study of strains of Halobacterium halobium differing in pigmentation.
Matsuno-Yagi A and 1 other. Biochem Biophys Res Commun, 1977. Cited by 241 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Two possible roles of bacteriorhodopsin; a comparative study of strains of Halobacterium halobium differing in pigmentation. Papers, record 20882. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20882
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Two possible roles of bacteriorhodopsin; a comparative study of strains of Halobacterium halobium differing in pigmentation.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteriorhodopsins | Major topic |
| Carotenoids | Major topic |
| Halobacterium | Major topic |
| Adenosine Triphosphate | |
| Hydrogen-Ion Concentration | |
| Hydroxylamines | |
| Light | |
| Species Specificity |
Source PubMed
Cited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 241 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,121,750 | Light-Based Molecular Tools to Precisely Monitor and Operate β-Adrenoceptors. | Med Res Rev | 2026 | https://conductscience.org/library/papers/41121750 | PubMed |
| 40,781,123 | A second photoactivatable state of the anion-conducting channelrhodopsin GtACR1 empowers persistent activity. | Commun Biol | 2025 | https://conductscience.org/library/papers/40781123 | PubMed |
| 39,178,949 | Direct detection of the chloride release and uptake reactions of Natronomonas pharaonis halorhodopsin. | J Biol Chem | 2024 | https://conductscience.org/library/papers/39178949 | PubMed |
| 39,155,779 | Optogenetics in oral and craniofacial research. | J Zhejiang Univ Sci B | 2024 | https://conductscience.org/library/papers/39155779 | PubMed |
| 38,362,336 | Potassium-selective channelrhodopsins. | Biophys Physicobiol | 2023 | https://conductscience.org/library/papers/38362336 | PubMed |
| 38,362,331 | Protein dynamics of a light-driven Na+ pump rhodopsin probed using a tryptophan residue near the retinal chromophore. | Biophys Physicobiol | 2023 | https://conductscience.org/library/papers/38362331 | PubMed |
| 38,362,329 | Structural studies of bacteriorhodopsin in BC era. | Biophys Physicobiol | 2023 | https://conductscience.org/library/papers/38362329 | PubMed |
| 38,362,324 | Biophysical characterization of microbial rhodopsins with DSE motif. | Biophys Physicobiol | 2023 | https://conductscience.org/library/papers/38362324 | PubMed |
| 37,596,487 | A comparative study reveals the relative importance of prokaryotic and eukaryotic proton pump rhodopsins in a subtropical marginal sea. | ISME Commun | 2023 | https://conductscience.org/library/papers/37596487 | PubMed |
| 37,424,998 | A bibliometric profile of optogenetics: quantitative and qualitative analyses. | Front Neurosci | 2023 | https://conductscience.org/library/papers/37424998 | PubMed |
| 36,982,781 | Development and Application of an Optogenetic Manipulation System to Suppress Actomyosin Activity in Ciona Epidermis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982781 | PubMed |
| 36,793,294 | Convergent evolution of animal and microbial rhodopsins. | RSC Adv | 2023 | https://conductscience.org/library/papers/36793294 | PubMed |
| 36,503,723 | Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration. | Prog Retin Eye Res | 2023 | https://conductscience.org/library/papers/36503723 | PubMed |
| 36,309,497 | Structural insights into light-driven anion pumping in cyanobacteria. | Nat Commun | 2022 | https://conductscience.org/library/papers/36309497 | PubMed |
| 36,213,746 | Applications and challenges of rhodopsin-based optogenetics in biomedicine. | Front Neurosci | 2022 | https://conductscience.org/library/papers/36213746 | PubMed |
| 36,180,556 | Mutations conferring SO42- pumping ability on the cyanobacterial anion pump rhodopsin and the resultant unique features of the mutant. | Sci Rep | 2022 | https://conductscience.org/library/papers/36180556 | PubMed |
| 35,857,224 | Searching Metagenomes for New Rhodopsins. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35857224 | PubMed |
| 35,857,222 | Molecular Biology of Microbial Rhodopsins. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35857222 | PubMed |
| 35,857,221 | Microbial Rhodopsins. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35857221 | PubMed |
| 35,401,082 | Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer's Disease. | Front Neurosci | 2022 | https://conductscience.org/library/papers/35401082 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20882
GET https://conductscience.org/api/papers/v1/20882/cited_by?page=2